NCT02593383View on ClinicalTrials.gov

Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Acne
Interventions
DRUG

Adapalene + Clindamycin Hydrochloride

0.1% Adapalene + 1% Clindamycin Hydrochloride

DRUG

Adapalene + Clindamycin Hydrochloride

0.1% Adapalene + 2% Clindamycin Hydrochloride

DRUG

Adapalene + Clindamycin Hydrochloride

0.05% Adapalene + 0.5% Clindamycin Hydrochloride

DRUG

Adapalene + Clindamycin Hydrochloride

0.05% Adapalene + 1% Clindamycin Hydrochloride

DRUG

Placebo

Trial Locations (1)

210042

Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY